Three North Korean companies are set to export their products to Russia this year in likely violation of international sanctions, official records show, after multiple DPRK firms sought entry into the Russian market amid rebounding ties in 2024.

According to Russia’s Federal Service for Accreditation (FSA), a Moscow-based sole proprietor filed four import declarations in early February to acquire medicinal goods from three North Korean companies.

The Pyongyang-based Namsong Pharmaceutical Company is expected to supply Kumdang-5 pills made from compressed ginseng roots to Vitaly Gonchar, a registered entrepreneur since 2015, according to FSA data.

The product falls under Harmonized System